Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Researchers led by Syracuse Universitys Robert Doyle have discovered a potential alternative to current GLP-1 weight loss drugs, which cause severe stomach upset in many patients, forcing them to discontinue treatment within a year
In a manually reviewed sample of 288 people classified as discontinuers, cost or insurance was the documented primary reason for 137, side effects for 42, and shortages for 34
For some employers, obesity-related GLP-1 costs have surpassed those for cancer and other high-cost specialty conditions
Frontier Peptide Labs BPC-157 + TB-500 is intended exclusively for laboratory research and development purposes
Whether youre exploring peptide therapy for weight management, healthy aging, recovery support, or overall wellness, our team can help determine whether treatment is right for you
